Its upregulation and immune associations in ARVC suggest that LIFR may contribute to disease progression by facilitating immune cell recruitment and sustaining an inflammatory cardiac microenvironment. Here, LIFR is linked to arrhythmogenic right ventricular cardiomyopathy.